|Bid||0.00 x 1300|
|Ask||0.00 x 1800|
|Day's range||291.82 - 304.37|
|52-week range||227.47 - 369.69|
|Beta (5Y monthly)||1.10|
|PE ratio (TTM)||63.12|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 1.56% and 0.76%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
As one of the biggest healthcare companies on the market and the world's largest robotic surgery company by far, Intuitive Surgical (NASDAQ: ISRG) has a lot of momentum. With its razor-and-blade business model, it has profitably sold the da Vinci robotic surgical suite and its associated surgical tools at a larger and larger scale since the early 2000s. On Jan. 12, Intuitive released a sneak peek of its performance in 2021, with the full results due on Jan. 20.
Identifying a company that can be a leader in its field for years to come is one of the rules to successful investing. This is what long-term investors of leading robotic surgical innovator Intuitive Surgical (NASDAQ: ISRG) experienced over the past five years. The company specializes in a market expected to grow at a 21.4% compound annual growth rate through 2028.